Vaccine manufacturers want to talk to central govt, says CM Kejriwal

The Delhi government has floated a Global Expression of Interest (EOI) for the procurement of vaccines

Topics
Coronavirus Vaccine | Coronavirus | Coronavirus Tests

ANI 

Kejriwal
Arvind Kejriwal, chief minister of Delhi | File photo

As the Delhi government has rolled out global tenders for procuring COVID-19 vaccines, Delhi Chief Minster Arvind Kejriwal has expressed his apprehensions regarding the procurement process, saying that most of the vaccine manufacturers globally prefers to talk only with the central government.

After inaugurating the drive-through vaccination centre in Chhatrasaal Stadium at Model Town today, Arvind Kejriwal said, "We have rolled out global tenders. All our efforts are on but other states that went for global tending so far did not receive encouraging results."

However, Chief Minister in furtherance added, "We have floated the tendering and are hopeful, it will be great if any company do come to us. But I think most of the renowned vaccine manufacturers in the world want to talk to the central government. Let's see how successful state government becomes."

The Delhi government has floated a Global Expression of Interest (EOI) for the procurement of 1 crore doses of Covid-19 vaccines on an urgent basis.

In the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authority of the government of India.

The Delhi government will accept an offer or expression of interest through e-mail by 5 pm on June 7. The efforts are part of efforts to ramp up the vaccination drive against Covid-19.

According to the latest bulletin by Delhi government 1141 positive cases, 71853 Tests conducted, 139 deaths were reported have been reported in the last 24 hours.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sat, May 29 2021. 16:54 IST
RECOMMENDED FOR YOU